USD 0.98
(-4.85%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 1.42 Million CAD | -50.09% |
2022 | 2.84 Million CAD | 328.06% |
2021 | 665.57 Thousand CAD | 0.0% |
2020 | - CAD | 0.0% |
2019 | - CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
2015 | - CAD | 0.0% |
2014 | - CAD | 0.0% |
2013 | - CAD | 0.0% |
2012 | - CAD | 0.0% |
2011 | - CAD | 0.0% |
2010 | - CAD | 0.0% |
2009 | - CAD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 1.4 Million CAD | -1.06% |
2023 Q4 | 1.42 Million CAD | -50.05% |
2023 Q3 | 2.84 Million CAD | -1.98% |
2023 FY | 1.42 Million CAD | -50.09% |
2023 Q1 | 1.17 Million CAD | -58.71% |
2023 Q2 | 2.9 Million CAD | 146.88% |
2022 Q2 | 1.46 Million CAD | 24.79% |
2022 Q3 | 2.84 Million CAD | 93.76% |
2022 FY | 2.84 Million CAD | 328.06% |
2022 Q4 | 2.84 Million CAD | 0.16% |
2022 Q1 | 1.17 Million CAD | 76.76% |
2021 Q1 | - CAD | 0.0% |
2021 Q3 | 271.04 Thousand CAD | 0.0% |
2021 Q4 | 665.57 Thousand CAD | 145.56% |
2021 Q2 | - CAD | 0.0% |
2021 FY | 665.57 Thousand CAD | 0.0% |
2020 Q3 | - CAD | 0.0% |
2020 Q1 | - CAD | 0.0% |
2020 FY | - CAD | 0.0% |
2020 Q4 | - CAD | 0.0% |
2020 Q2 | - CAD | 0.0% |
2019 Q3 | - CAD | 0.0% |
2019 Q4 | - CAD | 0.0% |
2019 FY | - CAD | 0.0% |
2019 Q1 | - CAD | 0.0% |
2019 Q2 | - CAD | 0.0% |
2018 Q2 | - CAD | 0.0% |
2018 Q1 | - CAD | 0.0% |
2018 FY | - CAD | 0.0% |
2018 Q4 | - CAD | 0.0% |
2018 Q3 | - CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 Q2 | - CAD | 0.0% |
2017 Q1 | - CAD | 0.0% |
2016 Q2 | - CAD | 0.0% |
2016 Q4 | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
2016 Q3 | - CAD | 0.0% |
2016 Q1 | - CAD | 0.0% |
2015 Q4 | - CAD | 0.0% |
2015 FY | - CAD | 0.0% |
2015 Q3 | - CAD | 0.0% |
2015 Q2 | - CAD | 0.0% |
2015 Q1 | - CAD | 0.0% |
2014 Q1 | - CAD | 0.0% |
2014 Q2 | - CAD | 0.0% |
2014 Q4 | - CAD | 0.0% |
2014 FY | - CAD | 0.0% |
2014 Q3 | - CAD | 0.0% |
2013 Q4 | - CAD | 0.0% |
2013 Q1 | - CAD | 0.0% |
2013 FY | - CAD | 0.0% |
2013 Q2 | - CAD | 0.0% |
2013 Q3 | - CAD | 0.0% |
2012 Q4 | - CAD | 0.0% |
2012 Q3 | - CAD | 0.0% |
2012 Q1 | - CAD | 0.0% |
2012 FY | - CAD | 0.0% |
2012 Q2 | - CAD | 0.0% |
2011 Q3 | - CAD | 0.0% |
2011 Q4 | - CAD | 0.0% |
2011 FY | - CAD | 0.0% |
2011 Q1 | - CAD | 0.0% |
2011 Q2 | - CAD | 0.0% |
2010 Q3 | - CAD | 0.0% |
2010 FY | - CAD | 0.0% |
2010 Q4 | - CAD | 0.0% |
2009 Q4 | - CAD | 0.0% |
2009 FY | - CAD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Akoya Biosciences, Inc. | 17.87 Million USD | 92.046% |
AngioDynamics, Inc. | 60.61 Million USD | 97.654% |
AtriCure, Inc. | 67.89 Million USD | 97.906% |
Avinger, Inc. | 5.29 Million USD | 73.16% |
Azenta, Inc. | 128.19 Million USD | 98.891% |
BioLife Solutions, Inc. | 43.45 Million USD | 96.728% |
The Cooper Companies, Inc. | 735.6 Million USD | 99.807% |
Daxor Corporation | - USD | -Infinity% |
Ekso Bionics Holdings, Inc. | 5.05 Million USD | 71.842% |
Femasys Inc. | 667.11 Thousand USD | -113.153% |
GlucoTrack, Inc. | - USD | -Infinity% |
Harvard Bioscience, Inc. | 24.71 Million USD | 94.247% |
Hologic, Inc. | 679.8 Million USD | 99.791% |
ICU Medical, Inc. | 709.36 Million USD | 99.8% |
Intuitive Surgical, Inc. | 1.22 Billion USD | 99.884% |
KORU Medical Systems, Inc. | 3.48 Million USD | 59.154% |
LeMaitre Vascular, Inc. | 52.33 Million USD | 97.283% |
Innovative Eyewear, Inc. | 856.75 Thousand USD | -65.972% |
Innovative Eyewear, Inc. | 856.75 Thousand USD | -65.972% |
Masimo Corporation | 545 Million USD | 99.739% |
Microbot Medical Inc. | - USD | -Infinity% |
Meihua International Medical Technologies Co., Ltd. | 1.61 Million USD | 12.073% |
Merit Medical Systems, Inc. | 303.87 Million USD | 99.532% |
Nephros, Inc. | 2.47 Million USD | 42.43% |
NovoCure Limited | 38.15 Million USD | 96.273% |
NEXGEL, Inc. | 1.31 Million USD | -7.808% |
NEXGEL, Inc. | 1.31 Million USD | -7.808% |
Singular Genomics Systems, Inc. | 13.57 Million USD | 89.523% |
OraSure Technologies, Inc. | 47.61 Million USD | 97.014% |
Pro-Dex, Inc. | 15.26 Million USD | 90.687% |
Pulse Biosciences, Inc. | - USD | -Infinity% |
Predictive Oncology Inc. | 494.37 Thousand USD | -187.633% |
Precision Optics Corporation, Inc. | 2.86 Million USD | 50.421% |
QuidelOrtho Corporation | 577.8 Million USD | 99.754% |
Repligen Corporation | 202.32 Million USD | 99.297% |
Sanara MedTech Inc. | 4.71 Million USD | 69.858% |
STAAR Surgical Company | 35.13 Million USD | 95.952% |
Sharps Technology, Inc. | 1.7 Million USD | 16.801% |
Utah Medical Products, Inc. | 9.58 Million USD | 85.16% |
DENTSPLY SIRONA Inc. | 624 Million USD | 99.772% |
Jin Medical International Ltd. | 5.05 Million USD | 71.859% |